FDA Stops Emergency Use of Hydroxychloroquine as it 'Weakens' Effectiveness of Remdesivir

FDA Stops Emergency Use of Hydroxychloroquine as it 'Weakens' Effectiveness of Remdesivir

Ibtimes·2020-06-16 13:21

Buy groceries and order food at affordable prices! Join WeBuy and #buyfresh together!
Want to study for an MBA? First understand these

The U.S. Food and Drug Administration (FDA) on Monday warned against using a combination of anti-malaria drug hydroxychloroquine and Gilead's experimental remdesivir on Covid-19 patients, as it could substantially reduce the effectiveness of the drug. The announcement came hours after the FDA revoked the emergency use of hydroxychloroquine as a potential Covid-19 treatment.

……

Read full article on Ibtimes

America Health Finance International

Comments

Leave a comment in Nestia App